To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 1
This profile is validated by 1 label.

Société

CBRA Genomics

CBRA Genomics_logo
21
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

CBRA Genomics is a Portuguese start-up, based in Cantanhede, that was founded in 2013 by Carlos Faro, Carlos Fiolhais, and Gonçalo Quadros. They envisioned a future where genomics would have fulfilled its potential.

Cantanhede, Center, Portugal

Envoyer un message

French

CBRA Genomics

French

CBRA Genomics is a Portuguese start-up, based in Cantanhede, that was founded in 2013 by Carlos Faro, Carlos Fiolhais, and Gonçalo Quadros. They envisioned a future where genomics would have fulfilled its potential, and would be routinely used within the clinical practice, with significant gains in healthcare and well-being, for individuals and families.
To support for their vision, CBRA Genomics has developed Elsie, an easy to use digital platform that fills the gap between...

En savoir plus

CBRA Genomics is a Portuguese start-up, based in Cantanhede, that was founded in 2013 by Carlos Faro, Carlos Fiolhais, and Gonçalo Quadros. They envisioned a future where genomics would have fulfilled its potential, and would be routinely used within the clinical practice, with significant gains in healthcare and well-being, for individuals and families.
To support for their vision, CBRA Genomics has developed Elsie, an easy to use digital platform that fills the gap between physicians, geneticists, and individuals, enabling the physicians to generate personalised diagnosis and prognosis reports in a safe, secure and efficient way, adapting the treatment plan and prescriptions considering the patient ́s genomic information. Therefore, the ultimate goal of ELSIE would be to improve healthcare and to foster personalized medicine.

  • 1

    Like

Membre(s) de l'équipe

Votre demande a bien été adressée
Rejoindre cette organisation
Your request has been sent

Membre(s) de l'équipe

Notre réseau

Votre demande a bien été envoyée
Rejoindre ce réseau
Votre message a bien été envoyé

Labels

InvestHorizon - Accelerated
454 Organisations

Communautés

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Membres